Valeant needs some painkillers after a Monday to forget
Beleaguered drugmaker Valeant Pharmaceuticals – one of the most widely-held names in the CLO market – was subject to yet more unwanted headlines yesterday
Related Stories
CLOs
- CVC joins short-dated trend for latest US CLO 5 hours ago
- CSAM gets happy ending as CLO 69 prices 5 hours ago
- European WAL test language is getting a little looser finds Dealscribe 6 hours ago
- New short-dated CLO brings triple-As down to 132bps 11 hours ago
- Oaktree makes it two new US CLOs this year 11 hours ago